已收盘 11-13 16:00:00 美东时间
-2.540
-1.21%
11月12日,Illumina(ILMN)收跌0.92%,报212.93美元,成交额4.02亿美元,市值321.95亿美元。 行情数据 • 开盘价:219.9...
11-12 05:40
Early access program launches to support ultrasensitive research into molecular residual disease and tumor evolution. New chemistry is optimized for highest possible accuracy, with reproducible detection of ctDNA at 2.5 parts per million levels with low sample input (10 nanograms) in representative ...
11-09 22:19
Early access program launches to support ultrasensitive research into molecular residual disease and tumor evolution. New chemistry is optimized for highest possible accuracy, with reproduci...
11-09 22:15
11月5日,Illumina(ILMN)收跌4.9%,报226.54美元,成交额6.91亿美元,市值342.08亿美元。 行情数据 • 开盘价:241美元 •...
11-05 05:40
11月4日,Illumina(ILMN)收涨5.13%,报238.21美元,成交额5.27亿美元,市值360.17亿美元。 行情数据 • 开盘价:233.14美...
11-04 05:39
Illumina(ILMN)最新财报显示,公司本季度实现营业收入11.29亿美元。 按业务划分: 1. Consumables 收入8.41亿美元,占总收入7...
11-04 04:01
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从50美元升至51美元;HC Wainwright & Co.:上调伊诺维奥制药评级至"买入",目标价5美元
11-03 18:20
今日重点评级关注:Canaccord Genuity:维持Viking Therapeutics"买入"评级,目标价从106美元升至118美元;Canaccord Genuity:维持Aclaris Therapeutics"买入"评级,目标价从10美元升至13美元
11-02 18:53